©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 14, 2014; 20(38): 13999-14003
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.13999
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.13999
Table 1 Baseline characteristics of the patients n (%)
| Time since disease diagnosis (yr) | 8.5 ± 7.3 |
| Age (yr) | 40.8 ± 12.1 |
| Gender (% female) | 56 (52.3) |
| BMI (kg/m2) | 25.2 ± 4.9 |
| Location | |
| Ileum | 39 (36.5) |
| Ileum and colon | 53 (49.5) |
| Colon | 15 (14) |
| Pattern | |
| Inflammatory | 29 (27.1) |
| Stenotic | 58 (54.2) |
| Fistulizing | 20 (18.7) |
| Ileocecal valve resection | 63 (58.9) |
| Treatment | |
| Immunosuppressant1 | 62 (57.9) |
| Biological treatment2 | 21 (19.6) |
| Double (immunosuppressant + biological) | 13 (12.1) |
| Proton pump inhibitors | 19 (17.8) |
| Bacterial overgrowth | 18 (16.8) |
| Presence of symptoms (n = 102) | 55 (51.4) |
| Bowel frequency (24 h) | 2.8 ± 2 |
- Citation: Sánchez-Montes C, Ortiz V, Bastida G, Rodríguez E, Yago M, Beltrán B, Aguas M, Iborra M, Garrigues V, Ponce J, Nos P. Small intestinal bacterial overgrowth in inactive Crohn’s disease: Influence of thiopurine and biological treatment. World J Gastroenterol 2014; 20(38): 13999-14003
- URL: https://www.wjgnet.com/1007-9327/full/v20/i38/13999.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i38.13999